Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Kv4.3 (Potassium voltage-gated channel subfamily D member 3) is a voltage-gated potassium channel encoded by the KCND3 gene. It is a key component of the transient outward potassium current (Ito), which plays a crucial role in the early repolarization phase of cardiac action potentials and contributes to A-type currents in neurons. Its function is modulated by auxiliary proteins like KChIPs and NCSs and post-translational modifications. Mutations or dysregulation of Kv4.3/KCND3 have been linked with cardiac arrhythmias including Brugada syndrome and neurological disorders.
Block Kv4.3 channels
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Potassium voltage-gated channel subfamily D member 3 (Kv4.3).